Basit Abdul, Fawwad Asher, Abdul Basit Khalid, Waris Nazish, Tahir Bilal, Siddiqui Iftikhar Ahmed
Department of Medicine, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan
Department of Biochemistry, Baqai Medical University, Karachi, Pakistan.
BMJ Open Diabetes Res Care. 2020 May;8(1). doi: 10.1136/bmjdrc-2019-001058.
Glycated hemoglobin (HbA1c) cut-off values as diagnostic tool in diabetes and prediabetes with its concordance to oral glucose tolerance test (OGTT) in Pakistani population.
Data for this substudy was obtained from second National Diabetes Survey of Pakistan (NDSP) 2016-2017. With this survey, 10 834 individuals were recruited and after excluding known subjects with diabetes, 6836 participants fulfilled inclusion criteria for this study. Demographic, anthropometric and biochemical parameters were obtained. OGTT was used as standard diagnostic tool to screen population and HbA1c for optimal cut-off values. Participants were categorized into normal glucose tolerance (NGT), newly diagnosed diabetes (NDD) and prediabetes.
Out of 6836 participants, 4690 (68.6%) had NGT, 1333 (19.5%) had prediabetes and 813 (11.9%) had NDD by OGTT criteria with median (IQR) age of 40 (31-50) years. Optimal HbA1c cut-off point for identification of diabetes and prediabetes was observed as 5.7% ((AUC (95% CI)=0.776 (0.757 to 0.795), p<0.0001)) and 5.1% ((AUC (95% CI)=0.607 (0.590 to 0.624), p<0.0001)), respectively. However, out of 68.6% NGT subjects identified through OGTT, 24.1% and 9.3% participants were found to have prediabetes and NDD, respectively by using HbA1c criteria. By using both OGTT and HbA1c criteria, only 7.9% and 7.3% were observed as prediabetes and diabetes, respectively.
Findings from second NDSP demonstrated disagreement between findings of OGTT and HbA1c as diagnostic tool for Pakistani population. As compared with international guidelines, HbA1c threshold for prediabetes and NDD were lower in this part of world. HbA1c as diagnostic tool might require ethnic or regional-based modification in cut-off points, validated by relevant community-based epidemiological surveys.
糖化血红蛋白(HbA1c)临界值作为糖尿病和糖尿病前期诊断工具及其与巴基斯坦人群口服葡萄糖耐量试验(OGTT)的一致性。
本亚组研究的数据来自2016 - 2017年巴基斯坦第二次全国糖尿病调查(NDSP)。通过该调查,招募了10834人,在排除已知糖尿病患者后,6836名参与者符合本研究的纳入标准。获取了人口统计学、人体测量学和生化参数。OGTT被用作筛查人群的标准诊断工具,同时确定HbA1c的最佳临界值。参与者被分为正常糖耐量(NGT)、新诊断糖尿病(NDD)和糖尿病前期。
在6836名参与者中,根据OGTT标准,4690名(68.6%)为NGT,1333名(19.5%)为糖尿病前期,813名(11.9%)为NDD,年龄中位数(四分位间距)为40(31 - 50)岁。用于识别糖尿病和糖尿病前期的最佳HbA1c临界值分别为5.7%(曲线下面积(95%置信区间)=0.776(0.757至0.795),p<0.0001)和5.1%(曲线下面积(95%置信区间)=0.607(0.590至0.624),p<0.0001)。然而,在通过OGTT确定的68.6%的NGT受试者中,分别使用HbA1c标准发现24.1%和9.3%的参与者患有糖尿病前期和NDD。同时使用OGTT和HbA1c标准时,分别仅有7.9%和7.3%被诊断为糖尿病前期和糖尿病。
第二次NDSP的研究结果表明,对于巴基斯坦人群,OGTT和HbA1c作为诊断工具的结果存在差异。与国际指南相比,该地区糖尿病前期和NDD的HbA1c阈值较低。作为诊断工具,HbA1c的临界值可能需要根据种族或地区进行调整,并通过相关的社区流行病学调查进行验证。